Rare disease drugmaker Shire Pharmaceuticals Plc (SHP.L) is preparing to announce its roughly $32.5 billion acquisition of U.S. peer Baxalta International Inc (BXLT.N) as early as Monday, according to people familiar with the matter.
The deal would come after Reuters first reported on Dec. 22 that Shire’s latest offer for Baxalta had met the latter’s valuation expectations. It would be one of the healthcare sector’s largest mergers in 2016.
A drifting barge was about an hour away from hitting BP's oil installations at the…
Investor enthusiasm for highly valued private tech companies waned substantially in the fourth quarter last…
Apple suppliers Cirrus Logic Inc and Qorvo Inc estimated third-quarter revenue below analysts' expectations, exacerbating…
The alliance between automakers Renault and Nissan will launch more than 10 cars with self-driving…
Yahoo is working on a plan to cut its workforce by at least 10 percent…
Naspers, the largest listed company in Africa, said it was not worried about Netflix's arrival…